Anesthesia, Local, Incontinence, Urinary, Retention, Urinary, Urinary Catheters
Conditions
Keywords
Urinary catheterization, Gel installation, Novel medical device, Indwelling urinary catheter, Long-term urinary catheter, Male patients
Brief summary
A randomized, open label, controlled, parallel group study to investigate difference between regional standard procedure and a novel modified procedure (using an additional novel device to facilitate gel installation) for changing long-term indwelling urinary catheters.
Detailed description
This is a randomized, open label, controlled, parallel group study, which comprises one visit that includes: assessment for eligibility, randomization to one of two treatment alternatives, followed by the actual intervention and evaluation of outcomes. The interventions are either change of catheter according to the regional standard procedure (the comparator group) or change of catheter with the additional use of the novel device to facilitate gel instillation and a slightly modified procedure (the experimental group).
Interventions
Catheter change with novel device Each subject will undergo catheter change with novel gel instillation device
Catheter change with standard procedure Each subject will undergo catheter change with standard procedure
Sponsors
Study design
Masking description
Open label
Intervention model description
Arm 1: Experimental: Novel device: Assigned Interventions: Catheter change with novel device. Each subject will undergo catheter change with novel gel instillation device. Arm 2: Comparator: Standard procedure: Assigned Interventions: Catheter change with standard procedure. Each subject will undergo catheter change with standard procedure.
Eligibility
Inclusion criteria
* The patient has an indwelling catheter and a primary diagnosis that justify continued catheter use * The patient provides informed consent prior to any study specific procedures * The patient is considered to benefit from participation in the clinical study
Exclusion criteria
* The patient do not consent to participate in the study * Trauma to urethra or bladder * Infection to urethra or bladder * Other diagnosis that contraindicates participation in the clinical study as judged by the responsible physician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Treatment duration (min) | During procedure | Treatment duration for procedure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient's perceived pain (NRS scale) | During intervention | Patient's perceived pain estimated by patient using a numerical rating scale (NRS-scale) |
| Number of gel syringes used | During intervention | Number of pre-filled gel syringes used during the procedure |
Other
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] | During intervention | Incidence of Treatment-Emergent Adverse Events found during procedure |
Countries
Sweden